For men | For women | |||||||
---|---|---|---|---|---|---|---|---|
Covariate | OR | 95% CI | p | OR | 95% CI | p | ||
Age (years) | .964 | .953 | .975 | < 0.001*** | .966 | .954 | .979 | < 0.001*** |
MAT type | .741 | .514 | 1.07 | 0.109 | .830 | .566 | 1.22 | 0.340 |
MAT dose (mg/day) | .999 | .996 | 1.00 | 0.449 | .996 | .993 | 1.00 | 0.025* |
Years on MAT | 1.00 | .972 | 1.03 | 0.928 | 1.00 | .977 | 1.03 | 0.768 |
Opioid-positive urine drug screens (% of total) | 1.01 | 1.00 | 1.01 | < 0.001*** | .998 | .994 | 1.00 | 0.429 |
Physical symptoms | 1.05 | 1.03 | 1.06 | < 0.001*** | 1.02 | 1.00 | 1.04 | 0.051 |
Psychological symptoms | 1.03 | 1.02 | 1.05 | < 0.001*** | 1.04 | 1.03 | 1.06 | < 0.001*** |